Subtype
Virus-Related Malignant Neoplasm
CI-CAN-00001652Explore in graph →
- NCIt
- C27673
Loading cancer entity…
Subtype
CI-CAN-00001652Explore in graph →
Variants & evidence
4 evidence items mapped to this entity or its descendants, grouped by molecular profile, then therapy. 50 items per page.
| Therapy | Cancer | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| NOTCH1 L1678P1 | ||||||||
| Nirogacestat | Adult T-Cell Leukemia/Lymphoma | Predictive | C | Supports Sensitivity Response | 3 | submitted | EID5921Genetic evaluation of a single patient with a complete response in a phase 1 trial of PF-03084014 revealed the presence of a known activating NOTCH1 mutation, L1678P. PMID 26407235 · Papayannidis et al., 2015 · Open in CIViC | civic |
| PLCG1 S345F1 | ||||||||
| (oncogenic) | Adult T-Cell Leukemia/Lymphoma | Oncogenic | D | Supports Oncogenicity | 3 | submitted | EID11795The PLCG1 S345F mutation has been reported as a hotspot mutation in adult T-cell Leukemia/Lymphoma (ATL). This study performed in vitro characterization of the mutation by identifying an ATL cell line… (full text at CIViC) PMID 36442790 · Prawiro et al., 2023 · Open in CIViC | civic |
| PRKCB D427N1 | ||||||||
| (diagnostic) | Adult T-Cell Leukemia/Lymphoma | Diagnostic | D | Supports Positive | 3 | accepted | EID6654PRKCB was mutated in 33% of ATLL cases. 93% of these mutations were within the catalytic domain at Asp427. This gene has not been reported to be significantly mutated in any other cancers. Indeed thi… (full text at CIViC) PMID 26437031 · Kataoka et al., 2015 · Open in CIViC | civic |
| PRKCB Mutation1 | ||||||||
| (prognostic) | Adult T-Cell Leukemia/Lymphoma | Prognostic | D | Supports Poor Outcome | 3 | submitted | EID11794For aggressive adult T cell leukemia/lymphoma (ATL), PRKCB mutations were associated with an adverse outcome (Hard Ratio: 2.07; 95% CI: 1.29-3.31; P-value: 0.003). In this study, 414 ATL patients were… (full text at CIViC) PMID 29084771 · Kataoka et al., 2018 · Open in CIViC | civic |
Data updated 8 hours agoSource updated unknownsource: civic (CC0)
Evidence levels, directions and ratings are those assigned by CIViC curators. "Submitted" items have not completed curation review. This is not treatment guidance.